Clinical Trial Update: An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC) [Phase 2]

View source ↗

Summary

Phase II open-label trial comparing nivolumab plus ipilimumab versus platinum-based chemotherapy plus nivolumab in chemonaive metastatic or recurrent squamous-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Lung Carcinoma

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Fondazione Ricerca Traslazionale | Conditions: Squamous-Cell Lung Cancer | Phase 2 | Status: UNKNOWN